Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (17466)	3/15/1998 1:34:00 PM
From: Phil Cressman	Respond to of 32384

Henry, slightly off topic - Hodgkinsons's Disease Would you know if Ligand's compounds would be indicated for use on or off label for this cancer of the Lymph Node's. A very dear old friend of my wife (she's now 53) has been through the whole rad and chemo procedure twice now (due mainly to the fact her GP over 5 years of complaints failed to properly diagnose so early treatment could have been done). Although able to work and get arround she has been told her body will not stand further treatment and her future is bleak indeed. Knowing that I've held Ligand stock for quite a while now my wife asked for any suggestions that could be passed on to her oncologist here in Canada. If there is a drug of potential benefit in Phase II testing I'd certainly do everything possible to get exemption from Canadian Authorities to see if trial use could be obtained.